Algeria – IPSEN to enter into Joint-Venture for local manufacturing

February 17, 2013 1:07 pm0 commentsViews: 704

HydraPharma is Algeria #1 Wholesaler/Distributor with an annual turnover of 430 million USD

Hydrapharm private group, leader in the distribution of pharmaceutical and para-pharmaceutical products, will be now actively engaged in the production of drugs in solid dosage forms by entering into a manufacturing partnership with Ipsen Pharma.

This Leader in the distribution of pharmaceutical and para-pharmaceutical products in Algeria has announced that on February 23rd it will sign a partnership agreement (Joint-Venture-) with Ipsen Pharma, a global pharma company. This partnership will allow the manufacturing of dry forms at HydraPharm’s brand new production unit in Khemis Miliana (Ain Defla – 100 km from Algiers).

They plan the production of 2.5 to 3 million boxes of Smecta (diosmectite – antidiarrheal drug) annually imported by Algeria. The contract, which will be operational immediately in 2013, aims to cover the national demand in diosmectite to switch the import into local manufacturing. This new project fits within the strategy deployed by Hydrapharm to reach the status of local manufacturer after more than a decade of import & distribution activity.

At a cost of 2.3 billion dinars (~ 30 million USD)  and the creation of 180 direct jobs, the first phase  of this project involves the launch of a first production line with an installed capacity of 11 million effective boxes on 2500 m². Four production lines are already planned for the first phase, in full and without conditioning process. A second phase and other financial commitments are planned from 2014 on additionnal 2000 m² and an extensions is planned for 2015 on an area of ​​13 000 m².

Other partnership including foreign companies are projected and under discussion, some of them very advanced. Thus, Hydrapharm is now involved in the development of local production industry, in accordance with the wishes of the Algerian government.

Launched in 1996, the group Hydrapharm currently structured into eight subsidiaries, has a staff of 1400 employees and four regional units and works directlyw ith over 3000 pharmacies in Algeria and has an annual turnover of 430 million USD.

[by Chérif Bennaceur -]

Comment this Post

You must be logged in to post a comment.

Recent Comments